MEGSA statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Driver mutation prioritization chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

MEGSA specifications


Unique identifier OMICS_08312
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages R
Computer skills Advanced
Stability Stable
Maintained Yes


Add your version


  • person_outline Jianxin Shi <>

Publication for MEGSA

MEGSA in publication

PMCID: 5162102
PMID: 27986087
DOI: 10.1186/s13059-016-1114-x

[…] solve the issues encountered with existing tests. we compared the performance of discover to that of several other published mutual exclusivity tests: memo [], muex [], mutex [], comet [], megsa [], and timex []. across the whole range of significance levels, discover is more sensitive while controlling the false positive rate at the specified level., we also applied discover […]

To access a full list of publications, you will need to upgrade to our premium service.

MEGSA institution(s)
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Bethesda, MD, USA

MEGSA reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review MEGSA